Unit of Global Health, Department of Health Sciences, University of Groningen, University Medical Center, Groningen, The Netherlands
Faculty of Pharmacy, Bhakti Kencana University, Bandung, Indonesia.
BMJ Open Respir Res. 2023 Nov;10(1). doi: 10.1136/bmjresp-2023-001887.
Optimal pharmacological treatment of tuberculosis (TB) requires a multidisciplinary team, yet the hospital pharmacist's role is unclear. We aimed to analyse hospital pharmacist-provided clinical pharmacy services (CPS) implementation in TB care.
A nationwide survey-based online cross-sectional study was conducted on hospital pharmacists in Indonesia from 1 November 2022 to 22 November 2022. Outcomes were the extent of pharmacists' involvement in multidisciplinary TB care, TB-related CPS provided and views on TB-related CPS. The probability of pharmacists' involvement in multidisciplinary TB teams was assessed using logistic regression.
In total, 439 pharmacists (mean age 31.2±6.22 years, 78% female) completed the survey. Thirty-six per cent were part of multidisciplinary TB care, and 23% had TB-related tasks. Adherence monitoring (90%) and drug use evaluation (86%) were the most conducted TB-related CPS. Pharmacists' views on TB-related CPS implementation were generally positive, except for financial incentives. Work experience (OR 1.99, 95% CI 1.09 to 3.61), ever received TB-related training (OR 3.51, 95% CI 2.03 to 6.14) and specific assignments to provide TB-related CPS (OR 8.42, 95% CI 4.99 to 14.59) significantly increased pharmacist involvement in multidisciplinary TB care.
Around one-third of hospital pharmacists are part of multidisciplinary TB care, with medication adherence and drug use monitoring as primary tasks. Pharmacists' experience, training, assignment to provide TB-related CPS and financial incentives are key elements for further implementation in multidisciplinary TB care. Pharmacists should proactively support current TB care and conduct operational research, sharing data with healthcare peers and fostering a collaborative multidisciplinary TB care team.
结核病(TB)的最佳药物治疗需要多学科团队,但医院药师的角色尚不清楚。我们旨在分析医院药师在结核病护理中提供的临床药学服务(CPS)的实施情况。
2022 年 11 月 1 日至 11 月 22 日,对印度尼西亚的医院药师进行了一项全国性的基于调查的在线横断面研究。结果是药师参与多学科结核病护理的程度、提供的与结核病相关的 CPS 以及对与结核病相关的 CPS 的看法。使用逻辑回归评估药师参与多学科结核病团队的可能性。
共有 439 名药师(平均年龄 31.2±6.22 岁,78%为女性)完成了调查。36%的药师参与了多学科结核病护理,23%的药师有与结核病相关的任务。药物依从性监测(90%)和药物使用评估(86%)是开展最多的与结核病相关的 CPS。药师对与结核病相关的 CPS 实施的看法普遍较为积极,但对财务激励措施除外。工作经验(OR 1.99,95%CI 1.09 至 3.61)、接受过与结核病相关的培训(OR 3.51,95%CI 2.03 至 6.14)和提供与结核病相关的 CPS 的特定任务(OR 8.42,95%CI 4.99 至 14.59)显著增加了药师参与多学科结核病护理的可能性。
约三分之一的医院药师参与了多学科结核病护理,以药物依从性和药物使用监测为主要任务。药师的经验、培训、提供与结核病相关的 CPS 的任务分配和财务激励是在多学科结核病护理中进一步实施的关键要素。药师应积极支持当前的结核病护理,并开展运营研究,与医疗保健同行共享数据,培养协作的多学科结核病护理团队。